Kalaris Therapeutics, Inc.
NASDAQKLRS short interest jumped 28% in one week to 4.2% of float, though shares fell 0.86% on May 13. Utilization plunged to 15.16%, lowest in weeks, as cost to borrow eased to 3.1%. Stock down 23% in one month. Earnings due May 20.
Snapshot as of 28 Jun 2026
Kalaris Therapeutics heads into its May 20 earnings event with shorts aggressively rebuilding after months of unwinding — just days after a Q1 beat failed to stop the stock sliding. The short interest story here is the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KLRS — free to start on ORTEX.
Sign up for free →Open KLRS on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live KLRS data →